 |
|
|
| |
Twenty-Eight Day Safety and Efficacy of Tenofovir Alafenamide in Chronic Hepatitis B Patients
|
| |
| |
Reported by Jules Levin
APASL 2014, Brisbane, Australia
Edward J. Gane,1 Kosh Agarwal,2 Scott K. Fung,3 Tuan T. Nguyen,4 Wendy Cheng,5 Eric Sicard,6 Stephen D. Ryder,7 John F. Flaherty,8 Eileen Lawson,8 Sally Zhao,8 Mani Subramanian,8 John G. McHutchison,8 Graham R. Foster9
1Auckland Clinical Studies, Auckland, New Zealand; 2Institute of Liver Studies, Kings College Hospital, London, UK; 3Toronto General Hospital, Toronto, Ontario, Canada; 4T. Nguyen Research and Education, San Diego, CA, USA; 5Royal Perth Hospital, Perth, Western Australia, Australia;
6Algorithme Pharma, Montreal, Quebec, Canada; 7Nottingham University Hospitals NHS Trust and Biomedical Research Unit, Nottingham, UK; 8Gilead Sciences, Inc., Foster City, CA, USA; 9Queen Mary's University of London, Barts Health, UK
|
| |
|
|
|
|
|
